{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-13",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "0031-8744",
      "generic_name": "acetaminophen, dextromethorphan hydrobromide, and doxylamine succinate",
      "labeler_name": "Haleon US Holdings LLC",
      "brand_name": "Robitussin Maximum Strength Severe Multi-Symptom 7 in 1 Relief Nighttime",
      "active_ingredients": [
        {
          "name": "ACETAMINOPHEN",
          "strength": "325 mg/1"
        },
        {
          "name": "DEXTROMETHORPHAN HYDROBROMIDE",
          "strength": "15 mg/1"
        },
        {
          "name": "DOXYLAMINE SUCCINATE",
          "strength": "6.25 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "0031-8744-10",
          "description": "5 BLISTER PACK in 1 CARTON (0031-8744-10)  / 2 CAPSULE, LIQUID FILLED in 1 BLISTER PACK",
          "marketing_start_date": "20180701",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "Haleon US Holdings LLC"
        ],
        "rxcui": [
          "1094549"
        ],
        "spl_set_id": [
          "e7cf7c5d-5c9a-4201-9e30-1cd616071855"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "362O9ITL9D",
          "9D2RTI9KYH",
          "V9BI9B5YI2"
        ]
      },
      "marketing_category": "OTC MONOGRAPH DRUG",
      "dosage_form": "CAPSULE, LIQUID FILLED",
      "spl_id": "156fd078-37b4-ddce-e063-6294a90ae226",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20150701",
      "product_id": "0031-8744_156fd078-37b4-ddce-e063-6294a90ae226",
      "application_number": "M012",
      "brand_name_base": "Robitussin Maximum Strength Severe Multi-Symptom 7 in 1 Relief Nighttime",
      "pharm_class": [
        "Antihistamine [EPC]",
        "Histamine Receptor Antagonists [MoA]",
        "Sigma-1 Agonist [EPC]",
        "Sigma-1 Receptor Agonists [MoA]",
        "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]",
        "Uncompetitive NMDA Receptor Antagonists [MoA]"
      ]
    }
  ]
}